The Week's Top Stories: Breakthrough COVID, FDA Approvals, and More

Article

This week's most-read stories discussed unforeseen consequences of the COVID-19 pandemic, including an increase in gastrointestinal diseases and a decrease in childhood asthma diagnoses.

Recent Videos
Related Content
Evolving Challenges in C difficile Testing: Diagnostic Stewardship or Laboratory Retrogress?

Evolving Challenges in C difficile Testing: Diagnostic Stewardship or Laboratory Retrogress?

Sophia Abene
June 19th 2025
Article
Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

George Sakoulas, MD
November 6th 2023
Podcast
RSV Prophylaxis: Palivizumab, Nirsevimab, and More

RSV Prophylaxis: Palivizumab, Nirsevimab, and More

Noah Christian, MD;Joseph M. Collaco, MD, PhD
May 9th 2025
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

Nina Cosdon
November 23rd 2022
Podcast
WHO, UNICEF, Gavi Warn of Global Increases of Vaccine-Preventable Diseases

WHO, UNICEF, Gavi Warn of Global Increases of Vaccine-Preventable Diseases

John Parkinson
April 29th 2025
Article
H5N1: The Outbreak the US Got Bored With

H5N1: The Outbreak the US Got Bored With

SASKIA V. POPESCU, PhD, MPH, MA, CIC
April 21st 2025
Article
© 2025 MJH Life Sciences

All rights reserved.